Literature DB >> 29922665

Helicobacter pylori: Does Gastritis Prevent Colitis?

Isabelle C Arnold1, Anne Müller1.   

Abstract

BACKGROUND: Since its discovery in the early 1980s, Helicobacter pylori has been linked to a variety of gastric and extragastric diseases. Chronic infection with H. pylori causes histologically evident gastritis in all colonized individuals and is the predominant risk factor for gastric and duodenal ulcers as well as gastric adenocarcinoma. However, increasingly robust experimental and epidemiological evidence suggests that H. pylori may at the same time be beneficial to its carriers, as it efficiently prevents allergic disorders and chronic inflammatory conditions. The purpose of this review is to summarize and document the latest evidence for a possible inverse association of H. pylori infection status and the risk of inflammatory bowel disease (IBD), as provided in both experimental and human observational studies. The pathogenesis of IBDs, the available mouse models for these diseases and the dual role of H. pylori in health and disease are presented in dedicated chapters. SUMMARY AND KEY MESSAGES: Almost all available epidemiological data suggest that H. pylori infection is inversely associated with both Crohn's disease (CD) and ulcerative colitis in European, Asian as well as American populations; large meta-analyses reviewing 30 original articles or more document that this inverse association is especially strong in CD patients and in children and young adults. Experimental data available from various mouse models of IBD confirm that live H. pylori infection as well as treatment with immunomodulatory molecules of H. pylori reduce clinical and histopathological IBD symptoms. Various proposed mechanisms involving the tolerization of dendritic cells, the production of protective cytokines and the preferential induction and differentiation of regulatory T-cells are presented. The implications of the beneficial aspects of the Helicobacter-host interaction for H. pylori eradication decisions, as well as potential new therapeutic options in the treatment of IBD are discussed in this review.

Entities:  

Keywords:  Bacterial immunomodulation; Epidemiological studies; Host/pathogen interaction; Microbiota and inflammatory bowel disease risk; Pathogenesis of gastritis and colitis

Year:  2016        PMID: 29922665      PMCID: PMC5988156          DOI: 10.1159/000445985

Source DB:  PubMed          Journal:  Inflamm Intest Dis        ISSN: 2296-9365


  94 in total

1.  IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting.

Authors:  Daniel C Baumgart; Charles N Bernstein; Zaigham Abbas; Jean F Colombel; Andrew S Day; Geert D'Haens; Iris Dotan; Khean L Goh; Toshifumi Hibi; Richard A Kozarek; Eamonn M M Quigley; Walter Reinisch; Bruce E Sands; Jose D Sollano; A Hillary Steinhart; Flávio Steinwurz; Morten H Vatn; Jesús K Yamamoto-Furusho
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

2.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

3.  A national study of Helicobactor pylori infection in gastric biopsy specimens.

Authors:  Amnon Sonnenberg; Richard H Lash; Robert M Genta
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

Review 4.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

5.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

6.  TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells.

Authors:  Ayca Sayi; Esther Kohler; Isabella M Toller; Richard A Flavell; Werner Müller; Axel Roers; Anne Müller
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

7.  Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis.

Authors:  Jay Luther; Stephanie Y Owyang; Tomomi Takeuchi; Tyler S Cole; Min Zhang; Maochang Liu; John Erb-Downward; Joel H Rubenstein; Chun-Chia Chen; Anna V Pierzchala; Jose A Paul; John Y Kao
Journal:  Gut       Date:  2011-04-06       Impact factor: 23.059

8.  The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1β production in Helicobacter pylori infected dendritic cells.

Authors:  Dong-Jae Kim; Jong-Hwan Park; Luigi Franchi; Steffen Backert; Gabriel Núñez
Journal:  Eur J Immunol       Date:  2013-07-25       Impact factor: 5.532

9.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

Authors:  L A Dieleman; B U Ridwan; G S Tennyson; K W Beagley; R P Bucy; C O Elson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

10.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

View more
  3 in total

1.  Is the Presence of Helicobacter Pylori in the Colonic Mucosa, Provocative of Activity in Ulcerative Colitis?

Authors:  Javad Ranjbar; Bita Geramizadeh; Kamran Bagheri Lankarani; Zahra Jowkar; Mitra Mirzai; Elham Moazamian
Journal:  Clin Pathol       Date:  2022-05-12

2.  Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation.

Authors:  Zhengqi Wang; Tamisha Y Vaughan; Wandi Zhu; Yuhong Chen; Guoping Fu; Magdalena Medrzycki; Hikaru Nishio; Silvia T Bunting; Pamela A Hankey-Giblin; Asma Nusrat; Charles A Parkos; Demin Wang; Renren Wen; Kevin D Bunting
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

3.  Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice.

Authors:  Fuzheng Tao; Xi Xing; Jiannong Wu; Ronglin Jiang
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.